Assessing for Diabetes-related Complications
The duration of type 2 diabetes is increasing owing to the global trend towards obesity and younger age of onset. Screening for microvascular and macrovascular complications is recommended for people with either type 1 or type 2 diabetes. People with type 1 diabetes should be screened for associated autoimmune conditions. Treatment targets, especially glycated haemoglobin level (HbA1c), should be individualised, taking into account relative risk and potential adverse effects.
Modern Medicine – Issue 3 2022
